Capstone Investment Advisors »

Syndax Pharmaceuticals shares owned by Capstone Investment Advisors

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Capstone Investment Advisors from 13F filings

Historical chart of Capstone Investment Advisors investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by Capstone Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $235k 11k 21.61

More positions owned by Capstone Investment Advisors

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Tesla Motors Call Option (TSLA)
Meta Platforms Cl A Call Option (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C Put Option (GOOG)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr Msci Emg Mkt Etf Put Option (EEM)
Select Sector Spdr Tr Financial Call Option (XLF)
Broadcom Call Option (AVGO)

View all positions for Capstone Investment Advisors

Top funds holding Syndax Pharmaceuticals

Wellington Management Company
Kynam Capital Management
Vanguard Group
venBio Select Advisor
Avidity Partners Management
Point72 Asset Management
Marshall Wace
BVF
OrbiMed Advisors
Franklin Resources
Goldman Sachs Group
Cormorant Asset Management
Bank of America Corporation
Aisling Capital Management
Candriam Luxembourg S.C.A.

View all funds holding Syndax Pharmaceuticals